Creative Biolabs Updates Antibody Catalog for COVID-19 Research

SHIRLEY, N.Y. - Aug. 2, 2020 - PRLog -- The SARS-COV-2 is rampaging throughout the world, posing threat to the health of human beings, hindering the economic growth of many countries, meanwhile challenging the current medical technologies.

As a reliable supplier of engineered antibody products, Creative Biolabs has instantly launched emergency plans to join the fight against COVID-19. With the experience gained when dealing with SARS and MERS epidemics, Creative Biolabs quickly organized over 400 types of therapeutic antibodies that can be applied to the study on COVID-19, which target crucial genes such as NP, S1, S1 RBD, S2 of SARS-CoV-2, SARS-CoV, and MERS-CoV.

Catalog of SARS-CoV-2 antibody (https://www.creativebiolabs.net/search?key=2019-nCOV&ty=product&cid=0) products

* 2019-nCoV NP

Rabbit Anti-SARS-CoV-2 (2019-nCoV) NP Recombinant Antibody

Human Anti-SARS-CoV-2 (2019-nCoV) NP Recombinant Antibody

Rabbit Anti-SARS-CoV-2 (2019-nCoV) NP Polyclonal Antibody

* 2019-nCoV S

Mouse Anti-2019-nCoV S1 Recombinant Antibody

Rabbit Anti-SARS-CoV-2 (2019-nCoV) S1 Recombinant Antibody

Human Anti-SARS-CoV-2 (2019-nCoV) S1 Recombinant Antibody

Mouse Anti-SARS-CoV-2 (2019-nCoV) S (RBD) Recombinant Antibody

Mouse Anti-SARS-CoV-2 (2019-nCoV) S (RBD) Polyclonal Antibody

Human Anti-SARS-CoV-2 (2019-nCoV) S2 Recombinant Antibody

Features:

* The majority of those antibody products are applicable for ELISA and WB. Other applications like Neut, Biosensors, Dot, FACS, FC, etc. can also find counterparts.

* All of the above-mentioned antibodies are obtained from mammalian, including camelid, human, mouse, rodent

Empowered by the sophisticated hybridoma development and phage display systems, Creative Biolabs can develop the recombinant antibodies efficiently and cost-effectively, which are also guaranteed with high purity, high specificity, and with low or no immunogenicity. Since the outbreak of COVID-19, Creative Biolabs has received a large number of orders requesting the antibodies.

To better alleviate badly needs on detection kits, Creative Biolabs is providing 3 types of kits for SARS-COV-2 detection, which can effectively make up for the deficiencies of nucleic acid tests, to generate instant testing results.

Detection Kits based on Fluorescent RT-PCR Method/Colloidal Gold Method/ELISA

The good news is that several vaccines have made huge breakthroughs in their clinical tests, with hundreds of candidates still on the way. As for the institutes and pharmaceutical companies that are dedicated to developing new drugs and vaccines against COVID-19, Creative Biolabs is always willing to offer first-level products and solutions. More details can be accessed at https://www.creativebiolabs.net/.